CSF Presenilin-1 complexes are increased in Alzheimer's disease. 2013

María-Salud García-Ayllón, and María-Letizia Campanari, and Gunnar Brinkmalm, and Alberto Rábano, and Jordi Alom, and Carlos A Saura, and Niels Andreasen, and Kaj Blennow, and Javier Sáez-Valero
Instituto de Neurociencias de Alicante, Universidad Miguel Hernández-CSIC, Av, Ramón y Cajal s/n, Sant Joan d'Alacant E-03550, Spain. j.saez@umh.es.

BACKGROUND Presenilin-1 (PS1) is the active component of the amyloid precursor protein cleaving γ-secretase complex. PS1 protein is a transmembrane protein containing multiple hydrophobic regions which presence in cerebrospinal fluid (CSF) has not been measured to date. This study assesses whether PS1 and other components of the γ-secretase complex are present in CSF. RESULTS Here, we show that PS1 is present in ventricular post-mortem and lumbar ante-mortem CSF, and plasma as 100-150-kDa hetero-complexes containing both the N- and C-terminal fragments (NTF and CTF) of the protein. Immunoprecipitation and immunoblotting with different antibodies confirmed the identity of the PS1 species. The γ-secretase components, APH-1 (anterior pharynx-defective 1) and PEN-2 (presenilin enhancer 2), as well as presenilin-2 (PS2) fragments, co-exist within these CSF complexes, while nicastrin is not detected. These CSF-PS1 complexes differ from active γ-secretase membrane-complexes, and may represent nonspecific aggregation of the PS1 protein. Levels of PS1 complexes are increased in CSF samples from autopsy-confirmed Alzheimer's disease (AD) cases and were found to be more stable than complexes in CSF from control subjects. Despite similar levels of total PS1 in CSF from probable AD patients and cognitively normal subjects, an increased proportion of highly stable PS1 complexes were observed in AD CSF. CONCLUSIONS Our data suggest that fragments of the PS1 protein present in CSF as complexes may be useful as a biomarker for AD.

UI MeSH Term Description Entries
D008159 Lumbar Vertebrae VERTEBRAE in the region of the lower BACK below the THORACIC VERTEBRAE and above the SACRAL VERTEBRAE. Vertebrae, Lumbar
D008297 Male Males
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010447 Peptide Hydrolases Hydrolases that specifically cleave the peptide bonds found in PROTEINS and PEPTIDES. Examples of sub-subclasses for this group include EXOPEPTIDASES and ENDOPEPTIDASES. Peptidase,Peptidases,Peptide Hydrolase,Protease,Proteases,Proteinase,Proteinases,Proteolytic Enzyme,Proteolytic Enzymes,Esteroproteases,Enzyme, Proteolytic,Hydrolase, Peptide
D010450 Endopeptidases A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS. Endopeptidase,Peptide Peptidohydrolases
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

María-Salud García-Ayllón, and María-Letizia Campanari, and Gunnar Brinkmalm, and Alberto Rábano, and Jordi Alom, and Carlos A Saura, and Niels Andreasen, and Kaj Blennow, and Javier Sáez-Valero
June 2000, Nature,
María-Salud García-Ayllón, and María-Letizia Campanari, and Gunnar Brinkmalm, and Alberto Rábano, and Jordi Alom, and Carlos A Saura, and Niels Andreasen, and Kaj Blennow, and Javier Sáez-Valero
February 1997, The American journal of pathology,
María-Salud García-Ayllón, and María-Letizia Campanari, and Gunnar Brinkmalm, and Alberto Rábano, and Jordi Alom, and Carlos A Saura, and Niels Andreasen, and Kaj Blennow, and Javier Sáez-Valero
January 1994, Neurobiology of aging,
María-Salud García-Ayllón, and María-Letizia Campanari, and Gunnar Brinkmalm, and Alberto Rábano, and Jordi Alom, and Carlos A Saura, and Niels Andreasen, and Kaj Blennow, and Javier Sáez-Valero
February 2021, International journal of molecular sciences,
María-Salud García-Ayllón, and María-Letizia Campanari, and Gunnar Brinkmalm, and Alberto Rábano, and Jordi Alom, and Carlos A Saura, and Niels Andreasen, and Kaj Blennow, and Javier Sáez-Valero
January 2017, Proceedings of the National Academy of Sciences of the United States of America,
María-Salud García-Ayllón, and María-Letizia Campanari, and Gunnar Brinkmalm, and Alberto Rábano, and Jordi Alom, and Carlos A Saura, and Niels Andreasen, and Kaj Blennow, and Javier Sáez-Valero
April 1996, Lancet (London, England),
María-Salud García-Ayllón, and María-Letizia Campanari, and Gunnar Brinkmalm, and Alberto Rábano, and Jordi Alom, and Carlos A Saura, and Niels Andreasen, and Kaj Blennow, and Javier Sáez-Valero
April 1996, Lancet (London, England),
María-Salud García-Ayllón, and María-Letizia Campanari, and Gunnar Brinkmalm, and Alberto Rábano, and Jordi Alom, and Carlos A Saura, and Niels Andreasen, and Kaj Blennow, and Javier Sáez-Valero
April 1996, Lancet (London, England),
María-Salud García-Ayllón, and María-Letizia Campanari, and Gunnar Brinkmalm, and Alberto Rábano, and Jordi Alom, and Carlos A Saura, and Niels Andreasen, and Kaj Blennow, and Javier Sáez-Valero
June 1996, Lancet (London, England),
María-Salud García-Ayllón, and María-Letizia Campanari, and Gunnar Brinkmalm, and Alberto Rábano, and Jordi Alom, and Carlos A Saura, and Niels Andreasen, and Kaj Blennow, and Javier Sáez-Valero
August 1996, Lancet (London, England),
Copied contents to your clipboard!